If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.50
Bid: 8.40
Ask: 8.60
Change: 0.30 (3.66%)
Spread: 0.20 (2.381%)
Open: 8.40
High: 8.55
Low: 8.40
Prev. Close: 8.20
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Meatly Creates Cans of Cultivated Pet Food

18 Mar 2024 07:00

RNS Number : 1402H
Agronomics Limited
18 March 2024
 

18 March 2024

Agronomics Limited

("Agronomics" or the "Company")

Meatly Creates the World's First Cans of Cultivated Pet Food Through Partnership

with Omni

 

Agronomics (LSE: ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company Good Dog Food Ltd (trading as "Meatly") has created the world's first cans of pet food that use cultivated chicken as a protein source. The product was created in collaboration with Meatly's first brand partner Omni Pet Ltd ("Omni"), a fast-growing novel protein pet food company in the UK, founded by veterinarian Dr Guy Sandelowsky.

 

Omni has achieved more than £2 million in sales to date selling dog food crafted from pulse, algae and yeast protein. The use of Meatly's cruelty-free chicken ingredient marks an important step in the mission of both companies to offer ethical and more environmentally friendly and healthy products for pets.

 

Once its product has been granted regulatory approval, Meatly-produced pet food will be made available in shops across the country through partnerships with retailers and manufacturers like Omni. As an early investor in Meatly, Pets at Home Limited plans to be the first retailer to offer these products in its stores.

 

Formerly known as 'Good Dog Food', the cultivated meat company rebranded as Meatly in November 2023 and has been working with the UK's Food Standards Agency and the Department for Environment Food & Rural Affairs to obtain approval for its cultivated chicken pet food to become available to buy in the UK.

 

Owen Ensor, Co-founder and CEO of Meatly, said:

 

"It is incredibly exciting to see the first ever cans of cultivated pet food fly off the production line. This is a major milestone for cultivated meat globally and shows that we are ready to sell product."

 

"As demand continues to grow, with pet food already accounting for 20% of meat produced globally, so too

does the industry's environmental impact. Cultivated meat gives pet parents an easy choice - high-quality,

tasty, nutritious, and sustainable pet food. We're thrilled to work with innovative companies like Omni to

make this a reality as soon as possible."

 

Jim Mellon, Agronomics' Executive Chairman added:

 

"This partnership shows the rapid progress Meatly has made in a very short period of time. Founded only 2 years ago, and with minimal capital, the company has now demonstrated it is ready to bring its product to market with key partners in the pet food industry. While regulatory approval has taken longer than anticipated, we are optimistic that Meatly's work with the governing authorities will be able to accelerate the timeline and launch its product shortly after."

 

About Meatly

Meatly (previously known as Good Dog Food) was founded in 2022 by CEO Owen Ensor and CSO Dr Helder Cruz

with backing from investor Agronomics. The company produces ethical and sustainable cultivated meat products

without compromising on essential nutritional benefits. Its current focus is on the pet food market. Learn more at http://meatly.pet.

 

About Agronomics

Agronomics is a leading listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and ingredients with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability and address human health, food security, and animal welfare. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

 

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBVKRSAUOARR
Date   Source Headline
23rd Dec 201612:00 pmRNSFinal Results and Notice of AGM
22nd Dec 20162:41 pmRNSLoan to the Diabetic Boot Company Ltd
12th Oct 20167:00 amRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSNet Asset Value(s)
29th Apr 20167:00 amRNSNet Asset Value calculation to 31 March 2016
15th Apr 20167:00 amRNSChange of Adviser
18th Mar 20167:00 amRNSHolding(s) in Company
17th Mar 20167:00 amRNSInterim Results for the six months to 31 Dec 2015
10th Feb 201612:11 pmRNSResult of AGM
25th Jan 20167:00 amRNSNet Asset Value(s)
22nd Dec 20157:00 amRNSAnnual Audited Results and Notice of AGM
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
4th Nov 20157:00 amRNSNet Asset Value(s)
30th Jul 20157:01 amRNSNet Asset Value(s)
15th Apr 20157:00 amRNSNet Asset Value as at 31 March 2015
30th Mar 20157:00 amRNSInterim results for 6 months to 31 December 2014
6th Feb 201512:21 pmRNSClose of Tender Offer
4th Feb 20155:36 pmRNSRe Results of Tender Offer
2nd Feb 20158:00 amRNSResults of Tender Offer
23rd Jan 20157:00 amRNSHolding(s) in Company
15th Jan 201511:56 amRNSHolding(s) in Company
14th Jan 20157:00 amRNSTender Offer
12th Jan 20159:32 amRNSNet Asset Value
30th Dec 20147:00 amRNSAnnual audited results
23rd Dec 201411:58 amRNSHolding(s) in Company
28th Nov 20142:04 pmRNSTender Offer in respect of Magna Biopharma
21st Oct 20147:00 amRNSNet Asset Value to 30 September 2014
22nd Jul 20147:00 amRNSNet Asset Value(s)
8th Apr 20147:00 amRNSNet Asset Value calculations to 31 March 2014
31st Mar 20147:00 amRNSInterim Results for the six months to 31 Dec 2013
24th Jan 201411:21 amRNSHolding(s) in Company
20th Jan 201410:56 amRNSHolding(s) in Company
17th Jan 20147:00 amRNSNet Asset Value(s)
15th Jan 20147:00 amRNSAppointment of Nominated Adviser
6th Jan 20145:49 pmRNSHolding(s) in Company
20th Nov 20134:04 pmRNSHolding(s) in Company
13th Nov 20135:13 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSResult of General Meeting
24th Oct 20137:01 amRNSNotice of General Meeting
24th Oct 20137:00 amRNSAnnual Financial Report
18th Oct 201311:23 amRNSHolding(s) in Company
18th Oct 20137:00 amRNSNet Asset Value(s)
4th Oct 20132:13 pmRNSHolding(s) in Company
26th Sep 20135:10 pmRNSHolding(s) in Company
13th Sep 201311:32 amRNSHolding(s) in Company
6th Sep 20135:29 pmRNSHolding(s) in Company
6th Aug 20139:40 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSNet Asset Value(s)
15th Apr 201312:34 pmRNSDirectorate Change
12th Apr 20132:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.